Blinkcns, Zucker Institute partner on blink reflex technology for neurological disorders

Blinkcns Inc. and the Zucker Institute for Innovation Commercialization at the Medical University of South Carolina have announced a licensing agreement to advance blink reflex technology and software EyeStat.

“We are delighted to have established this new licensing agreement, which represents significant clinical potential for our technology,” Jeff Riley, executive chairman of Blinkcns, said in a company release. “The foundation of this relationship is strong and helps to build internal and external confidence in our corporate mission.”

According to the release, the EyeStat medical device uses a small stimulus of carbon dioxide, light flash or audio prompt to trigger the blink reflex and enable real-time data collection and analysis in less than 1 minute. The data can then be used by clinicians to determine whether abnormalities exist in the blink reflex and apply those findings to the identification of a variety of neurological conditions.

“It is especially exciting to see [Medical University of South Carolina] technologies licensed and commercialized by ‘home-grown’ biotech companies in Charleston,” Michael Yost, PhD, interim CEO of the Zucker Institute, said in the release. “This partnership gives us a platform for collaborating even more deeply with the Blinkcns team to better the lives of people around South Carolina, the United States and the world.”